loading

Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
8.19%
154.62
168.41 160.27 134.22 119.13
Cost Of Revenue
36.31%
27.48
43.15 32.30 25.01 20.78
Gross Profit
1.49%
127.13
125.26 127.97 109.21 98.35
Operating Expenses
11.72%
75.10
85.06 63.46 62.31 57.92
Interest Income/Expense
4.535
- - - -
Benefits Costs and Expenses
20.12%
102.83
128.72 108.44 90.12 81.35
Costs And Expenses
20.12%
102.83
128.72 108.44 90.12 81.35
Operating Income/Loss
29.45%
52.03
40.20 64.51 46.90 40.42
Income/Loss From Continuing Operations Before Tax
30.48%
51.78
39.69 51.83 44.09 37.78
Income Tax Expense/Benefit
2.82%
13.45
13.08 13.37 9.795 8.295
Income/Loss From Continuing Operations After Tax
44.07%
38.33
26.61 38.46 34.30 29.48
Net Income/Loss
44.07%
38.33
26.61 38.46 34.30 29.48
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
14,758%
56.77
-0.3873 59.86 59.97 59.73
Diluted Average Shares
11,164%
57.60
-0.5206 60.68 60.74 61.22
Basic Earnings Per Share
47.83%
0.68
0.46 0.64 0.57 0.49
Diluted Earnings Per Share
48.89%
0.67
0.45 0.63 0.56 0.48
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):